AIC
IRD

AWM Investment Company’s Opus Genetics IRD Stock Holding History

AWM Investment Company’s Portfolio IRD Stock Details IRD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$956K Buy
+232,590
New +$1.08M 0.08% 98
2025
Q2 		– Sell
-524,245
Closed -$515K – 104
2025
Q1 		$515K Buy
+524,245
New +$586K 0.07% 86

Other funds holding IRD

CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
BCM
BIOS Capital Management Fort Worth, Texas $41.7M AUM 34.92% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $80.2B AUM 51.53% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $3.01B AUM 119.46% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
BCM
Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return
TECP
Trails Edge Capital Partners Atlanta, Georgia $630M AUM
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

AWM Investment Company's IRD Position: Q2 2026 in Review

AWM Investment Company opened a new position in Opus Genetics (IRD) in Q2 2026: 232,590 shares worth $956K. The stake represents 0.08% of the portfolio and ranks #98 among its holdings. This is a return to the name: AWM Investment Company previously reported a position in IRD as recently as Q1 2025.

AWM Investment Company first reported a position in IRD in Q1 2025 and has held it in 2 quarters since. 103 funds tracked by Wall St. Rank hold IRD as of Q2 2026.

  • AWM Investment Company held 232,590 shares of Opus Genetics worth $956K as of Q2 2026.
  • Opus Genetics was a new AWM Investment Company position in Q2 2026.
  • Opus Genetics made up 0.08% of AWM Investment Company's portfolio in Q2 2026, its #98 holding.
  • AWM Investment Company first reported a position in Opus Genetics in Q1 2025 and has held it in 2 quarters since.
  • 103 funds tracked by Wall St. Rank held Opus Genetics as of Q2 2026.

Based on AWM Investment Company's 13F filing for Q2 2026, filed 14 Aug 2026.